Unicycive Therapeutics UNCY
NASDAQ UNCY
$5.63 +0.18 (+3.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026)

Unicycive Therapeutics' (UNCY) quarterly Prepaid Assets came in at $181000.0 in Q1 2026, down 86.77% YoY from $1.4 million in Q1 2025, and down 84.54% on a QoQ basis from $1.2 million in Q4 2025.

Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026) Analysis & Trends

Unicycive Therapeutics (UNCY) has 7 years of Prepaid Assets data on file, last reported at $181000.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 86.77% year-over-year to $181000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $181000.0 (down 86.77% YoY) and the FY2025 annual result came in at $1.2 million, up 24.71% from the prior year.
  • Prepaid Assets eased to $181000.0 in Q1 2026, from $1.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.6 million in Q3 2025 to a low of $15000.0 in Q2 2025.
  • A 5-year average of $2.0 million and a median of $1.8 million in 2022 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets jumped 19770.0% — and 2025, when it plunged 99.34%.
  • Tracing UNCY's Prepaid Assets over 5 years: stood at $159000.0 in 2022, then jumped by 2225.79% to $3.7 million in 2023, then tumbled by 74.61% to $939000.0 in 2024, then gained by 24.71% to $1.2 million in 2025, then tumbled by 84.54% to $181000.0 in 2026.
  • The last three Prepaid Assets figures came in at $181000.0 (Q1 2026), $1.2 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Unicycive Therapeutics 151.01 Mn 151.01 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 9.90 Mn
Mar 31, 2026 181,000.00
Dec 31, 2025 1.17 Mn
Sep 30, 2025 7.59 Mn
Jun 30, 2025 15,000.00
Mar 31, 2025 1.37 Mn
Dec 31, 2024 939,000.00
Sep 30, 2024 687,000.00
Jun 30, 2024 2.27 Mn
Mar 31, 2024 2.75 Mn
Dec 31, 2023 3.70 Mn
Sep 30, 2023 682,000.00
Jun 30, 2023 3.11 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 159,000.00
Sep 30, 2022 2.95 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 1.84 Mn
Dec 31, 2021 1.83 Mn
Sep 30, 2021 58,000.00